Palcigen 125 mg (Palbociclib), general Ibrance is a traditional drug used to treat hormone receptor (HR) positive, mortal epidermal growth factor receptor 2 (HER2) negative advanced bone cancer in women who have endured menopause.
Palcigen is manufactured by General Pharmaceuticals Limited
. in Bangladesh.
Have to take orally formerly a day with food for 21 successive days followed by 7 days off treatment to comprise a complete cycle of 28 days.
The most common adverse response
Nausea, puking, loss of appetite, diarrhea, frazzle, weakness, hair loss, mouth blisters, or impassiveness/ tingling of arms/ legs.
The below information comes from the Internet. Please consult with the croaker for medical advice.
PI & Suggestions
* Any advice on the use of the medicine is for reference only. Please consult with a croaker for medical advice. All Names, ensigns, and trademarks are the property of their separate possessors. Watermarks and QR canons are used for identification purposes only.